Xalabrands Xalabrands [Member] Xalabrands Australian Taxation Office Australian Taxation Office [Member] Hedging Designation [Domain] Hedging Designation [Domain] Share repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Gains and Losses on Marketable Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Goodwill Disposal Group, Including Discontinued Operation, Goodwill Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Earnings per Share Policy Earnings Per Share, Policy [Policy Text Block] Accounts receivable, net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Number of restricted stock awards, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Consolidated Entities [Axis] Consolidated Entities [Axis] Taxes related to the net share settlement of equity awards Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Payroll and employee benefit liabilities Employee-related Liabilities, Current Interest cost Defined Benefit Plan, Interest Cost Income Statement Location [Axis] Income Statement Location [Axis] Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Range [Domain] Statistical Measurement [Domain] Receivable Type [Axis] Receivable Type [Axis] Minimum Repayments on Outstanding Borrowings Schedule of Maturities of Long-term Debt [Table Text Block] Accounts payable Disposal Group, Including Discontinued Operation, Other Liabilities, Current Segment Reporting Policy Segment Reporting, Policy [Policy Text Block] Dividends, Common Stock, Cash Dividends, Common Stock, Cash Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code 2023 Senior Notes (3.125% coupon) SeniorNotesTwoThousandTwentyThree3.125Percent [Member] Senior notes two thousand twenty three - 3.125 percent 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan [Member] 2020 Stock Incentive Plan and 2003 Long-Term Incentive Plan Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Weighted average grant-date fair value per share, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Non-contingent payments for product rights Payment for Contingent Consideration Liability, Financing Activities Yupelri ® Yupelri ® [Member] Yupelri ® Restructuring Type [Axis] Restructuring Type [Axis] Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Other assets Other assets Other Assets, Noncurrent Investment, Name [Axis] Investment, Name [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Segments [Axis] Segments [Axis] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity File Number Entity File Number Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense Income Tax Examination, Partial Payment Of Income Tax Expense 2023 Long-Term Debt, Maturity, Year Two Stock compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Income taxes Increase (Decrease) in Income Taxes Payable Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure 2032 Euro Senior Notes 2032 Euro Senior Notes [Member] 2032 Euro Senior Notes 2043 Senior Notes (5.400% coupon) SeniorNotesTwoThousandFortyThree [Member] Senior notes two thousand forty three Net unrecognized (loss) gain on derivatives Net unrecognized gain (loss) on derivatives Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax, Parent Viagra ® Viagra ® [Member] Viagra ® Percent Of Total Assets Impacted, High Inflationary Economy Percent Of Total Assets Impacted, High Inflationary Economy Percent Of Total Assets Impacted, High Inflationary Economy Subsequent Event Type [Domain] Subsequent Event Type [Domain] Revenue Recognition and Deferred Revenue [Abstract] Revenue Recognition and Deferred Revenue [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Intangible asset amortization expense Amortization of Intangible Assets Amortization of Intangible Assets Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Payments of financing fees Payments of Financing Costs Net unrecognized gain on derivatives in net investment hedging relationships, net of tax Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Accumulate Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Net Investment Hedges, Effect Net of Taxx Clean Energy Partnerships [Member] Clean energy investments Clean Energy Partnerships [Member] Clean Energy Partnerships Anti-dilutive stock options or restricted stock awards excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Inventories Schedule of Inventory, Current [Table Text Block] Program Name [Axis] Program Name [Axis] Program Name Liability Class [Axis] Liability Class [Axis] EpiPen® Auto-Injectors EpiPen® Auto-Injectors [Member] EpiPen® Auto-Injectors Weighted average grant-date fair value per share, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Business Acquisition [Axis] Business Acquisition [Axis] Cash Flow Hedging Cash Flow Hedging [Member] Disposal Group Name [Axis] Disposal Group Name [Axis] North America Segment North America Segment [Member] North America Segment Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Award Type [Domain] Award Type [Domain] Local Phone Number Local Phone Number Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Additional cash payments to be received Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High Disposal Group, Including Discontinued Operation, Consideration, Contingent Consideration Arrangements, Range Of Outcomes, High ASSETS Assets [Abstract] 2024 Long-Term Debt, Maturity, Year Three Accumulated impairment losses, beginning balance Accumulated impairment losses, ending balance Goodwill, Impaired, Accumulated Impairment Loss Exercisable at June 30, 2022 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Vested and expected to vest at June 30, 2022 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Reconciling items: Segment Reconciling Items [Member] Number of restricted stock awards, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Accounting Standards Update and Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding at December 31, 2021 Outstanding at June 30, 2022 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Retained Earnings Retained Earnings [Member] Retained Earnings [Member] Debt Instrument [Axis] Debt Instrument [Axis] Fair value of long-term debt Debt Instrument, Fair Value Disclosure 2020 Euro Senior Notes 2020 Euro Senior Notes [Member] 2020 Euro Senior Notes [Member] Litigation Commitments and Contingencies Disclosure [Text Block] Available-for-sale fixed income investments Debt Securities [Member] Business Combination, Contingent Consideration, Liability, Measurement Input Business Combination, Contingent Consideration, Liability, Measurement Input Accounts receivable Increase (Decrease) in Accounts Receivable Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Measurement Input, Estimated Tax Rate Measurement Input, Estimated Tax Rate [Member] Measurement Input, Estimated Tax Rate [Member] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Other comprehensive (loss) earnings, before tax Other comprehensive (loss) earnings, before tax Other Comprehensive Income (Loss), before Tax 2020 Restructuring Plan 2020 Restructuring Plan [Member] 2020 Restructuring Plan Basic (in USD per share) Basic earnings (loss) per share attributable to Viatris Inc. shareholders Earnings Per Share, Basic Proceeds from sale of assets and subsidiaries Proceeds from Sales of Business, Affiliate and Productive Assets Revenue Recognition and Accounts Receivable Revenue from Contract with Customer [Text Block] Unusual Risk or Uncertainty [Table] Unusual Risk or Uncertainty [Table] Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Goodwill Impairment, Measurement Input, Term Number of restricted stock awards, nonvested beginning of period Number of restricted stock awards, nonvested end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2022 Long-Term Debt, Maturity, Year One Unamortized debt issuance expense Unamortized Debt Issuance Expense Other Current Portion of Long-term Debt Other Current Portion of Long-term Debt [Member] Other Current Portion of Long-term Debt [Member] Prepaid expenses Prepaid Expense, Current Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] 2026 Long-Term Debt, Maturity, Year Five Reporting Unit [Domain] Reporting Unit [Domain] Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Reporting Unit, Amount of Fair Value in Excess of Carrying Amount Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable Employee benefit liabilities Liability, Defined Benefit Pension Plan, Noncurrent Measurement Input, Terminal Year Revenue Growth Rate Measurement Input, Terminal Year Revenue Growth Rate [Member] Measurement Input, Terminal Year Revenue Growth Rate Machinery and equipment Machinery and Equipment [Member] Commercial Paper [Member] Commercial Paper [Member] Ordinary shares reserved for issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Change in short-term borrowings, net Proceeds from (Repayments of) Short-term Debt Other non-cash items Other Noncash Income (Expense) Fair value of financial instruments Derivative Asset, Fair Value, Gross Asset Number of cases Number of cases Number of cases JANZ Japan, Australia and New Zealand Segment [Member] Japan, Australia and New Zealand Segment Net unrecognized gain on derivatives in cash flow hedging relationships Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Other payables Accounts Payable, Other Trade receivables, net Receivables, Net, Current Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Schedule of other current liabilities [Table] Equity securities Debt Securities, Trading, and Equity Securities, FV-NI Total Long-term Debt, Gross Goodwill [Roll Forward] Goodwill [Roll Forward] Reporting Unit [Axis] Reporting Unit [Axis] Plan Name [Axis] Plan Name [Axis] Long-term debt Long-term Debt Other Liabilities, Other than Long-term Debt, Noncurrent Total assets at recurring fair value measurement Assets, Fair Value Disclosure Level 1 Fair Value, Inputs, Level 1 [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Schedule of Cash, cash equivalents, and restricted cash Schedule of Cash, Cash Equivalents and Restricted Cash [Table Text Block] [Table Text Block] for Schedule of Cash, Cash Equivalents and Restricted Cash [Table] Entity Small Business Entity Small Business Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Total liabilities and equity Liabilities and Equity Other Other Accrued Liabilities, Current Scenario [Axis] Scenario [Axis] Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member] Additional paid-in capital Additional Paid in Capital 2048 Senior Notes (5.200%) SeniorNotesTwoThousandFortyEight [Member] SeniorNotesTwoThousandFortyEight [Member] Intangible asset impairment charges Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Number of equity method investments Number of equity method investments Number of equity method investments 2.125% Euro Senior Notes due 2025 2025 Euro Senior Notes [Member] 2025 Euro Senior Notes [Member] Derivative [Line Items] Derivative [Line Items] Interest rate swaps Interest Rate Swap [Member] Hedging Relationship [Domain] Hedging Relationship [Domain] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Prepaid Expenses and Other Current Assets Schedule of Other Current Assets [Table Text Block] Income Tax Contingency [Table] Income Tax Contingency [Table] 2026 Senior Notes (3.950% coupon) SeniorNotesTwoThousandTwentySix3.95Precent [Member] 2026 Senior Notes 3.950% Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Intangible assets, net Disposal Group, Including Discontinued Operation, Intangible Assets Earnings (Loss) per Ordinary Share Earnings Per Share [Text Block] Assets held for sale Disposal Group, Including Discontinued Operation, Assets Operating expenses: Operating Expenses [Abstract] Agency mortgage-backed securities Collateralized Mortgage Backed Securities [Member] Entity Interactive Data Current Entity Interactive Data Current Thereafter Long-Term Debt, Maturity, after Year Five 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Abstract] Minimum Minimum [Member] Recognized net actuarial losses Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement General Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Note Securitization Facility Note Securitization Facility [Member] Note Securitization Facility [Member] Tax related items, including contingencies Liability for Uncertainty in Income Taxes, Noncurrent Gross profit Gross loss Gross Profit Long-term Line of Credit Long-term Line of Credit Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Balance Sheet Location [Domain] Balance Sheet Location [Domain] SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] SeniorNotesTwoThousandTwentyEight [Member] Financial and Nonfinancial Liabilities, Fair Value Disclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure Selling, general and administrative Selling, General and Administrative Expense Income Tax Authority [Domain] Income Tax Authority [Domain] Entity Ordinary Shares, Shares Outstanding Entity Common Stock, Shares Outstanding Biocon Biologics Biocon Biologics [Member] Biocon Biologics Entity Address, State or Province Entity Address, State or Province Beginning Balance Ending Balance Restructuring Reserve Other Assets, Noncurrent [Abstract] Other Assets, Noncurrent [Abstract] Foreign currency translation Restructuring Reserve, Translation and Other Adjustment Other comprehensive earnings (loss) before reclassifications, before tax Other Comprehensive Income (Loss), before Reclassifications, before Tax Deferred income tax benefit Deferred Income Tax Assets, Net Current liabilities: Liabilities, Current [Abstract] 2025 Long-Term Debt, Maturity, Year Four Receivable [Domain] Receivable [Domain] Stock Issued During Period, Value, New Issues Stock Issued During Period, Value, New Issues Cash flows from investing activities: Payments to Acquire Businesses, Net of Cash Acquired Restructuring Plan [Domain] Restructuring Plan [Domain] Foreign Currency Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Debt Debt Disclosure [Text Block] Other Exit Costs Other Restructuring [Member] Exercisable at June 30, 2022 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Line of Credit [Member] Line of Credit [Member] Share-Based Incentive Plan Share-based Payment Arrangement [Text Block] Senior Notes Senior Notes [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Restructuring Reserve, Settled without Cash Restructuring Reserve, Settled without Cash Net unrealized loss on marketable securities, net of tax AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax Derivative Instruments Risk [Axis] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Average remaining contractual term for stock awards outstanding, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Stock Issued During Period, Shares, New Issues Stock Issued During Period, Shares, New Issues Balance Sheet Components [Abstract] Balance Sheet Components [Abstract] Balance Sheet Components Schedule of other current liabilities [Line Items] Schedule of other current liabilities [Line Items] [Line Items] for Schedule of other current liabilities [Table] Document Transition Report Document Transition Report Common Stock, Value, Issued Common Stock, Value, Issued Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Weighted-average period over which total unrecognized compensation expense expected to be recognized, in years Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average grant-date fair value per share, nonvested beginning of period Weighted average grant-date fair value per share, nonvested end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Basis of Accounting Policy Basis of Accounting, Policy [Policy Text Block] Accumulated other comprehensive loss Accumulated other comprehensive loss: Accumulated Other Comprehensive Income (Loss), Net of Tax Dividends payable (in dollars per share) Dividends Payable, Amount Per Share Rebates, promotional programs and other sales allowances Accrued Sales Allowances Accrued Sales Allowances Entity Emerging Growth Company Entity Emerging Growth Company 2020 Senior Notes (3.750% coupon) Senior Notes Two Thousand Twenty - 3.75 Percent [Member] Senior Notes Two Thousand Twenty - 3.75 Percent Returns Revenue from Contract with Customer, Returns Revenue from Contract with Customer, Returns Percent ownership after transaction Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership Disposal Group, Including Discontinued Operation, Consideration, Convertible Preferred Equity, Percent Ownership Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] 2027 Senior Notes 2027 Senior Notes [Member] 2027 Senior Notes 2024 Euro Senior Notes 2024 Euro Senior Notes [Member] 2024 Euro Senior Notes [Member] Other Assets Schedule of Other Assets, Noncurrent [Table Text Block] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Legal Entity [Axis] Legal Entity [Axis] Cover [Abstract] Cover [Abstract] Revolving Facility Revolving Facility [Member] Revolving Facility Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Goodwill [Line Items] Goodwill [Line Items] Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Treasury stock, shares Balance (in shares) Balance (in shares) Treasury Stock, Shares Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Term of transition services agreement Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement Disposal Group, Including Discontinued Operations, Term Of Transition Services Agreement Income Tax Authority [Axis] Income Tax Authority [Axis] Work in process Inventory, Work in Process, Net of Reserves Multi District Litigation [Member] Multi District Litigation [Member] Multi District Litigation [Member] Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Unusual Risk or Uncertainty [Line Items] Unusual Risk or Uncertainty [Line Items] Entity [Domain] Entity [Domain] Short-term Debt [Line Items] Short-term Debt [Line Items] Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Net sales Sales Revenue, Goods, Net Revenue from Contract with Customer, Excluding Assessed Tax Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Schedule of Other Noncurrent Liabilities [Table] Finished goods Inventory, Finished Goods, Net of Reserves Corporate costs Corporate costs Corporate costs Consolidated Entity Consolidated Entity, Excluding VIE [Member] Stock awards Share-based Payment Arrangement, Option [Member] Other revenues Revenue Not from Contract with Customer Equity [Abstract] Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Net unrealized (loss) gain on marketable securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent Document Quarterly Report Document Quarterly Report Cash payment Payments for Restructuring Measurement Input Type [Domain] Measurement Input Type [Domain] Prepaid Expense and Other Assets [Abstract] Prepaid Expense and Other Assets [Abstract] Common Stock Marketable securities Common Stock [Member] Segment Information Segment Reporting Disclosure [Text Block] Earnings (loss) from operations Operating Income (Loss) Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] 2024 Euro Senior Notes, 1.023% 2024 Euro Senior Notes, 1.023% [Member] 2024 Euro Senior Notes, 1.023% Operating lease liability Operating Lease, Liability, Current Collaboration and Licensing Agreements Collaborative Arrangement Disclosure [Text Block] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Measurement Input, Reduction in Terminal Year Revenue Growth Rate Measurement Input, Reduction in Terminal Year Revenue Growth Rate [Member] Measurement Input, Reduction in Terminal Year Revenue Growth Rate Hedging Designation [Axis] Hedging Designation [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Foreign currency translation adjustment Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Share-based compensation expense Share-based Payment Arrangement, Noncash Expense Restructuring Restructuring and Related Activities Disclosure [Text Block] Inventories Disposal Group, Including Discontinued Operation, Inventory, Current Additional Paid-In Capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Net unrecognized gain on derivatives in cash flow hedging relationships, net of tax Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Dividends paid (in dollars per share) Common Stock, Dividends, Per Share, Cash Paid Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] 2046 Senior Notes (5.250% coupon) SeniorNotesTwoThousandFortySix5.25Precent [Member] 2046 Senior Note (5.250%) Treasury Stock Treasury Stock [Member] Generics Generics [Member] Generics Goodwill, Transfers Goodwill, Transfers Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Other expense, net Other Nonoperating Income (Expense) Pension and other postretirement benefits Other Pension, Postretirement and Supplemental Plans [Member] Payments for product rights and other, net Payments for (Proceeds from) Other Investing Activities Capital expenditures Payments to Acquire Property, Plant, and Equipment Other current liabilities Equity method investments, clean energy investments Other Liabilities, Current Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Maximum Maximum [Member] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 2028 Euro Senior Notes 2028 Euro Senior Notes [Member] 2028 Euro Senior Notes [Member] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Total liabilities Liabilities Raw materials Inventory, Raw Materials, Net of Reserves Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Award Type [Axis] Award Type [Axis] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Schedule of Activity in Contingent Consideration [Roll Forward] Measurement Input Type [Axis] Measurement Input Type [Axis] Consolidation Items [Axis] Consolidation Items [Axis] Restructuring and Related Cost, Expected Cost Remaining Restructuring and Related Cost, Expected Cost Remaining Creon ® Creon ® [Member] Creon ® City Area Code City Area Code Restricted cash Restricted Cash and Cash Equivalents, Current Equity Method Investments Equity Method Investments and Joint Ventures Disclosure [Text Block] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Change in unrecognized gain (loss) and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Entity Address, City or Town Entity Address, City or Town Current Portion of Long-Term Debt Current Portion of Long-Term Debt [Member] Viatris Inc. shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Number of states Number of states Number of states Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] 2050 Senior Notes 2050 Senior Notes [Member] 2050 Senior Notes Schedule of Short-term Debt [Table] Schedule of Short-term Debt [Table] Operating Lease, Liability, Noncurrent Operating Lease, Liability, Noncurrent Interest expense Interest Expense Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Net unrecognized gain and prior service cost related to defined benefit plans, net of tax Net unrecognized losses and prior service cost related to defined benefit plans, net of tax Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Retained earnings Retained Earnings (Accumulated Deficit) Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Operating Segment Operating Segments [Member] Litigation Case Type [Domain] Litigation Case [Domain] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Stock option award expiration period, in years Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Contingent consideration payments Payments of Merger Related Costs, Financing Activities Restricted stock awards Restricted Stock Units (RSUs) [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Equity Method Investments Equity Method Investments [Table Text Block] Entity Filer Category Entity Filer Category Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Anticompetitive Conduct with Generic Drugs [Member] Developed Markets Developed Markets Segment [Member] Developed Markets Segment Other Other Long Term Debt [Member] Other long term debt. U.S. Treasuries US Treasury Securities [Member] Valuation Technique, Discounted Cash Flow Valuation Technique, Discounted Cash Flow [Member] Income Statement [Abstract] Income Statement [Abstract] Celebrex ® Celebrex ® [Member] Celebrex ® Entity Registrant Name Entity Registrant Name Asset Class [Domain] Asset Class [Domain] 2028 Senior Notes [Member] 2028 Senior Notes [Member] 2028 Senior Notes [Member] [Member] New Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Accretion expense Accretion Expense In-process research and development Indefinite-lived Intangible Assets (Excluding Goodwill) Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Total equity Balance Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Income tax (benefit) provision Income Tax Expense (Benefit) Accounts receivable, net Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Amendment Flag Amendment Flag Proceeds from issuance of long-term debt Proceeds from Issuance of Long-term Debt Equity Components [Axis] Equity Components [Axis] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Unusual or Infrequent Item, or Both Unusual or Infrequent Item, or Both [Member] Entity Tax Identification Number Entity Tax Identification Number Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Other comprehensive (loss) earnings, before tax: Other Comprehensive Income (Loss), before Tax [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Gains and Losses on Derivatives Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Trade accounts payable Accounts Payable, Trade Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Number of restricted stock awards, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Inventories Inventories Inventory, Net Reconciliation of Segment Information to Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Equity Method Investments and Joint Ventures [Abstract] Equity Method Investments and Joint Ventures [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Business Combination, Contingent Consideration Arrangements, Reclassifications Current portion of long-term debt and other long-term obligations Long-term Debt, Current Maturities Product and Service [Axis] Product and Service [Axis] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Lyrica ® Lyrica ® [Member] Lyrica ® Restructuring Plan [Axis] Restructuring Plan [Axis] Biosimilars Portfolio Biosimilars Portfolio [Member] Biosimilars Portfolio Equity Component [Domain] Equity Component [Domain] Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Disposal Group Name [Domain] Disposal Group Name [Domain] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Statement [Line Items] Statement [Line Items] Litigation Case [Axis] Litigation Case [Axis] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Zoloft ® Zoloft ® [Member] Zoloft ® 2040 Senior Notes 2040 Senior Notes [Member] 2040 Senior Notes Weighted Average Exercise Price per Share Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Utilization Restructuring and Related Cost, Incurred Cost Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Retirement Plan Type [Domain] Retirement Plan Type [Domain] Liabilities Liabilities [Abstract] YEN Term Loan YEN Term Loan [Member] YEN Term Loan Available-for-sale securities Debt Securities, Available-for-sale Counterparty Name [Domain] Counterparty Name [Domain] Estimated Litigation Liability, Reduction For Payments Estimated Litigation Liability, Reduction For Payments Estimated Litigation Liability, Reduction For Payments Intangible assets, gross, excluding goodwill Intangible Assets, Gross (Excluding Goodwill) Debt Disclosure [Abstract] Debt Disclosure [Abstract] 2025 Senior Notes 2025 Senior Notes [Member] 2025 Senior Notes Chargebacks Chargebacks Chargebacks Purchase of marketable securities Payments to Acquire Marketable Securities Measurement Input, Long-term Revenue Growth Rate Measurement Input, Long-term Revenue Growth Rate [Member] Earnings before income taxes Operating and non-operating expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Level 2 Fair Value, Inputs, Level 2 [Member] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Corporate / Other Corporate, Non-Segment [Member] Type of Restructuring [Domain] Type of Restructuring [Domain] Segment Reporting [Abstract] Segment Reporting [Abstract] Finite-lived intangible assets, estimated useful life, in years Finite-Lived Intangible Asset, Useful Life Revenue of biosimilars portfolio Disposal Group, Including Discontinued Operation, Revenue Other expense Other Expense [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] TURKEY TURKEY Pension and Other Postretirement Benefits Disclosure Retirement Benefits [Text Block] Accounts payable Increase (Decrease) in Accounts Payable, Trade Basic and Diluted Earnings per Ordinary Share Attributable to Mylan N.V. Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Asset Class [Axis] Asset Class [Axis] Scenario, Forecast Forecast [Member] Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Foreign currency translation Goodwill, Translation and Purchase Accounting Adjustments Program Name [Domain] Program Name [Domain] [Domain] for Program Name Title of 12(b) Security Title of 12(b) Security Prepaid expenses and other current assets Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Issuance of common stock Proceeds from Issuance of Common Stock Total assets Assets Income tax provision (benefit) Other Comprehensive Income (Loss), Tax Litigation settlements and other contingencies, net Litigation settlements and other contingencies, net Gain (Loss) Related to Litigation Settlement EpiPen Auto-Injector Litigation EpiPen Auto-Injector Litigation [Member] EpiPen Auto-Injector Litigation Investment, Name [Domain] Investment, Name [Domain] Plan Name [Domain] Plan Name [Domain] Cash dividends paid Payments to Noncontrolling Interests Ordinary shares, shares authorized Common Stock, Shares Authorized Short-term Debt [Abstract] Short-term Debt [Abstract] Geographical [Domain] Geographical [Domain] Net earnings (loss) Net earnings (loss) attributable to Viatris Inc. common shareholders Net earnings (loss) Net Income (Loss) Available to Common Stockholders, Basic Document Type Document Type Mylan Mylan N.V. Parent Company [Member] Research and development Research and development Research and Development Expense Product and Service [Domain] Product and Service [Domain] Fair value loss Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Business Combination, Contingent Consideration, Liability, Fair Value Gain (Loss) Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Stated percentage rate Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Schedule of Accounts Receivable, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Derivative Contract Type [Domain] Derivative Contract [Domain] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Other long-term assets Other long-term assets Other long-term assets Contingent consideration Balance at beginning of period Balance at end of period Business Combination, Contingent Consideration, Liability Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Litigation settlements and other contingencies, net Change in noncash litigation settlements, net Change in noncash litigation settlements, net Revolving Credit Facility Revolving Credit Facility [Member] 2023 Senior Notes (4.200% coupon) SeniorNotesTwoThousandTwentyThree4.2Percent [Member] Senior notes two thousand twenty three - 4.2 percent Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Short-term borrowings Short-term Debt Revenue Recognition And Accounts Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Summary of Long-Term Debt Schedule of Debt [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Corporate Bond Securities [Member] Corporate Bond Securities [Member] Other assets Disposal Group, Including Discontinued Operation, Other Assets Other receivables Other Receivables, Net, Current Geographical [Axis] Geographical [Axis] Proceeds from sale of terminated interest rate swaps Proceeds from Sale of Securities, Operating Activities Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Corporate and Other Corporate and Other [Member] Basic Weighted average shares outstanding Weighted Average Number of Shares Outstanding, Basic Diluted (in USD per share) Diluted earnings (loss) per ordinary share Earnings Per Share, Diluted Segments [Domain] Segments [Domain] Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Sales Revenue, Gross to net adjustments Service cost Defined Benefit Plan, Service Cost Net Investment Hedging Net Investment Hedging [Member] Damages to be paid Loss Contingency, Damages Paid, Value Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Hedging Relationship [Axis] Hedging Relationship [Axis] Sales [Member] Sales [Member] Xanax ® Xanax ® [Member] Xanax ® Interest Expense [Member] Interest Expense [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Finite-lived Intangible Assets Amortization Expense Finite-lived Intangible Assets Amortization Expense [Table Text Block] Amortization of prior service costs Amortization of prior service costs Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Intangible assets, net Intangible assets, net book value, excluding goodwill Intangible Assets, Net (Excluding Goodwill) Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Employee Related Costs Employee Severance [Member] Restructuring Restructuring Reserve, Current Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Contingent consideration Contingent Consideration [Member] Contingent Consideration. Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Upfront payment subject to certain adjustments Disposal Group, Including Discontinued Operation, Cash Deferred income tax liability Deferred Income Tax Liabilities, Net Stock option award vesting period, in years Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Other long-term obligations Other Noncurrent Liabilities [Member] Variable Consideration Variable Consideration [Member] Variable Consideration [Member] Components of Other Comprehensive Loss Comprehensive Income (Loss) [Table Text Block] 2030 Senior Notes 2030 Senior Notes [Member] 2030 Senior Notes Loss from equity method investments Income (Loss) from Equity Method Investments Exchange traded funds Exchange Traded Funds [Member] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Nonvested Restricted Stock and Restricted Stock Unit Awards Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Charges Restructuring Charges 2027 Euro Senior Notes 2027 Euro Senior Notes [Member] 2027 Euro Senior Notes Depreciation and amortization Depreciation, Depletion and Amortization Measurement Input, Control Premium Measurement Input, Control Premium [Member] Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Financial Assets and Liabilities Carried at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Foreign Tax Authority Foreign Tax Authority [Member] Legal and professional accruals, including litigation accruals Estimated Litigation Liability, Current Accounts Payable, Current [Abstract] Accounts Payable, Current [Abstract] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] 2022 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Inventories Increase (Decrease) in Inventories Schedule of Other Noncurrent Liabilities [Line Items] Schedule of Other Noncurrent Liabilities [Line Items] [Line Items] for Schedule of Other Noncurrent Liabilities [Table] Restructuring - employee related Restructuring and Related Costs [Table Text Block] Derivative [Table] Derivative [Table] Cost of sales Cost of Goods and Services Sold Revenues [Abstract] Revenues [Abstract] Estimated employer contributions in current year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Document Period End Date Document Period End Date Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Entity Central Index Key Entity Central Index Key Proceeds from sale and collection of receivables Proceeds from Sale and Collection of Receivables Other Revenues Product and Service, Other [Member] Number of Shares Under Stock Awards Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Consolidated Entities [Domain] Consolidated Entities [Domain] Complex GX and Biosimilars Complex GX and Biosimilars [Member] Complex GX and Biosimilars Amitiza ® Amitiza ® [Member] Amitiza ® Emerging Markets Emerging Markets Segment [Member] Emerging Markets Segment Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Greater China Greater China Segment [Member] Greater China Segment Receivables Facility Receivables Facility [Member] Receivables facility. Income Statement Location [Domain] Income Statement Location [Domain] Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Medicaid and other governmental rebates Medicaid and other governmental rebates Medicaid and other governmental rebates Loss Contingencies [Line Items] Loss Contingencies [Line Items] Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Total operating expenses Operating Expenses Development and sales milestone payments Development and sales milestone payments Development and sales milestone payments Land and improvements Land and Land Improvements [Member] Other long-term obligations Other Liabilities, Noncurrent Expected Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Payments of long-term debt Repayments of Long-term Debt Trading Symbol Trading Symbol Earnings (loss) per share attributable to Viatris Inc. shareholders Earnings Per Share [Abstract] Earnings Per Share [Abstract] Collaborative Arrangement Collaborative Arrangement [Member] Equity method investments summarized financial data basis Equity Method Investments Summarized Financial Data Basis Equity Method Investments Summarized Financial Data Basis Property, plant and equipment, gross Property, Plant and Equipment, Gross Net unrecognized gain on derivatives in cash flow hedging relationships, net of tax AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax Total revenues Revenues Revenues Other Current Liabilities [Member] Other current liabilities Other Current Liabilities [Member] Vested and expected to vest at June 30, 2022 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Issuance of restricted stock, net of shares withheld Restricted Stock, Value, Shares Issued Net of Tax Withholdings Other Liabilities, Fair Value Disclosure Other Liabilities, Fair Value Disclosure Foreign currency forward contracts Foreign Exchange Contract [Member] Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class [Line Items] Intangible Assets by Major Class Amortization of actuarial loss included in SG&A Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax Loss Contingency Accrual Loss Contingency Accrual 2022 Euro Senior Notes 2022 Euro Senior Notes [Member] 2022 Euro Senior Notes Outstanding at December 31, 2021 Outstanding at June 30, 2022 Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Goodwill, gross, beginning balance Goodwill, gross, ending balance Goodwill, Gross Lipitor Lipitor ® [Member] Lipitor ® Long-term debt Long-term Debt, Excluding Current Maturities Long-term Debt, Excluding Current Maturities Patents and technologies Patents [Member] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Reserve for Uncertain Tax Positions, Including Interest And Penalties Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Average remaining contractual term for stock awards exercisable, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Entity Current Reporting Status Entity Current Reporting Status Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Other Litigation Other [Member] Other Other Debt Obligations [Member] Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Current portion of long-term debt Debt, Current Brands Brands [Member] Brands Counterparty Name [Axis] Counterparty Name [Axis] Proceeds from the sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Construction in progress Construction in Progress [Member] Dymista ® Dymista ® [Member] Dymista ® Cash, cash equivalents and restricted cash — beginning of period Cash, cash equivalents and restricted cash — end of period Cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Balance (in shares) Balance (in shares) Shares, Issued Common Stock, Par or Stated Value Per Share Ordinary shares, nominal value Common Stock, Par or Stated Value Per Share Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Measurement Input, EBITDA Multiple Measurement Input, EBITDA Multiple [Member] Current assets: Assets, Current [Abstract] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Other items, net Proceeds from (Payments for) Other Financing Activities Finite-lived intangible assets, original cost Finite-Lived Intangible Assets, Gross Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Defined benefit plans, estimated benefit payments, in current fiscal year Common Stock, Capital Shares Reserved for Future Issuance Common Stock, Capital Shares Reserved for Future Issuance Components of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Disposal Group Classification [Domain] Disposal Group Classification [Domain] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Accounts payable Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Business Combination Contingent Consideration Liability Payments Payments Business Combination Contingent Consideration Liability Payments Business Combination Contingent Consideration Liability Payments Diluted Total dilutive shares outstanding Weighted Average Number of Shares Outstanding, Diluted Other comprehensive (loss) earnings, net of tax Other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Total intangible asset amortization expense (including impairment charges) Amortization Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Amended Anticompetitive Conduct with Generic Drugs [Member] Estimated litigation liability Estimated Litigation Liability Income Taxes Income Tax Disclosure [Text Block] Accrued interest Interest Payable, Current Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Stock Awards Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Gain (Loss) on Fair Value Hedges Recognized in Earnings Gain (Loss) on Fair Value Hedges Recognized in Earnings Disposal Groups, Including Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Fair Value of Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Goodwill Impairment, Measurement Input Product Liability Product Liability [Member] Product Liability Not Designated as Hedging Instruments Not Designated as Hedging Instrument [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Restructuring Reserve, Noncurrent Restructuring Reserve, Noncurrent Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Buildings and improvements Building and Building Improvements [Member] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Issuance of restricted stock, net of shares withheld (in shares) Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Notional amount of derivative Derivative Asset, Notional Amount Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Greater China Europe Segment [Member] Europe Segment Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Weighted average grant-date fair value per share, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Entity Shell Company Entity Shell Company Effexor ® Effexor ® [Member] Effexor ® Total current liabilities Liabilities, Current Taxes paid related to net share settlement of equity awards Payment, Tax Withholding, Share-based Payment Arrangement Foreign exchange forward contracts Foreign Exchange Forward [Member] Norvasc Norvasc ® [Member] Norvasc ® Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Money market funds Money Market Funds [Member] Accounts payable Accounts payable Accounts Payable, Trade, Current Loss Contingencies [Table] Loss Contingencies [Table] Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date Financial Instruments and Risk Management Financial Instruments Disclosure [Text Block] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Long-Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Payments for Legal Settlements Payments for Legal Settlements Gross sales Revenue from Contract with Customer, Gross Revenue from Contract with Customer, Gross Percent Of Net Sales Impacted, High Inflationary Economy Percent Of Consolidated Net Sales Impacted, High Inflationary Economy Percent Of Consolidated Net Sales Impacted, High Inflationary Economy Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Other current assets Other Assets, Current Statement [Table] Statement [Table] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Asset-backed Securities Asset-backed Securities [Member] Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Total unrecognized compensation expense, net of estimated forfeitures Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Good will, After Amortization Expense, Before Reclassification Good will, After Amortization Expense, Before Reclassification Good will, After Amortization Expense, Before Reclassification Range [Axis] Statistical Measurement [Axis] Fair value of financial instruments Derivative Liability, Fair Value, Gross Liability Subsequent Event Subsequent Event [Member] Finite-lived intangible assets, net book value Finite-Lived Intangible Assets, Net Goodwill Goodwill Goodwill, net, beginning balance Goodwill, net, ending balance Goodwill Measurement Input, Increase in Discount Rate Measurement Input, Increase in Discount Rate [Member] Measurement Input, Increase in Discount Rate Income taxes payable Accrued Income Taxes, Current Changes in Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Scenario, Unspecified [Domain] Scenario [Domain] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Intellectual Property Developed Technology Rights [Member] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Defined Benefit Plan Items Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Deferred income tax (benefit) expense Deferred Income Tax Expense (Benefit) Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Other One-Time Nonoperating Expense Adjustments to reconcile net earnings (loss) to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] 2048 Senior Notes 2048 Senior Notes [Member] 2048 Senior Notes [Member] Average remaining contractual term for stock awards vested and expected to vest, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term